Clinical Trial Update: Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants in Taiwan has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• 13-valent pneumococcal conjugate vaccine (13-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Vaccines, Pneumococcal Conjugate Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2011-05-12